The article notes the importance of resistance exercise and adequate protein intake as mitigation strategies, and discusses the need for close monitoring in vulnerable groups
Key Takeaways Body contouring after Ozempic or Wegovy addresses the loose skin and softened shape that GLP-1 weight loss leaves behind
- Lm tng canxi: a s TPBS collagen c ngun gc t b, g, c,
Statements Author contributions All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication
She completed her postgraduate research at the University of Glasgow, focusing on metabolic complications of pregnancy and the role of adipose tissue function
#ObesityTherapeutics #GLP1 #TernsPharma #ObesityTreatment #ClinicalTrials #MetabolicHealth Terns Pharmaceuticals Halts Obesity Program After Underwhelming Phase 2 Data for Oral GLP-1 (TERN-601) Terns Pharmaceuticals announced topline 12-week Phase 2 FALCON results for its once-daily oral GLP-1 receptor agonist TERN-601 in adults with obesity (BMI 2750 kg/m, without diabetes), showing modest placebo-adjusted weight loss of 4.6%, below internal efficacy targets
